The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China

被引:0
作者
Jing Ni
Xianzhong Cheng
Qian Zhao
Zhiqin Dai
Xia Xu
Wenwen Guo
Hongyuan Gu
Rui Zhou
Yan Wang
Xiaoxiang Chen
机构
[1] The Affiliated Cancer Hospital of Nanjing Medical University,Department of Gynecologic Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research
[2] Nanjing Medical University Affiliated Cancer Hospital,Department of Chemotherapy
[3] Jiangsu Cancer Hospital,Department of Pathology
[4] Jiangsu Institute of Cancer Research,undefined
[5] The Second Affiliated Hospital of Nanjing Medical University,undefined
来源
Journal of Ovarian Research | / 14卷
关键词
Ovarian cancer; Niraparib; Real world; Efficacy; Safety; HRD;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
[21]   Clinical efficacy and safety of perampanel monotherapy as primary anti-seizure medication in the treatment of pediatric epilepsy: A single-center, prospective, observational study [J].
Gu, Yanxia ;
Li, Yue ;
Li, Wei ;
Chen, Feng ;
Wu, Chunfeng ;
Chen, Jing .
EPILEPSIA OPEN, 2024, 9 (06) :2209-2218
[22]   Niraparib in the maintenance treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: safety and efficacy [J].
Liu, Marisa C. ;
Sutedja, Joyce ;
Tewari, Krishnansu S. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (05) :475-480
[23]   Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety [J].
Reggia, Rossella ;
Franceschini, Franco ;
Tincani, Angela ;
Cavazzana, Ilaria .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (02) :193-195
[24]   Efficacy and safety of the combination of anlotinib and envafolimab in the treatment of unresectable or metastatic liposarcoma: findings from a single-center retrospective study [J].
Liu, Hongliang ;
Hao, Qisheng ;
Wang, Xi ;
Cheng, Mengxing ;
Qiu, Fabo ;
Zhou, Bin .
FRONTIERS IN ONCOLOGY, 2025, 14
[25]   Real-world applications of PARPi maintenance therapy for recurrent ovarian cancer: A single-center study in China [J].
Wang, Deng-Feng ;
Shi, Xun-Wei ;
Zhang, Can ;
Zhang, Jie ;
Liu, Hong ;
Huang, Jian-Ming ;
Zhang, Guo-Nan ;
Wen, Qing-Lian .
GYNECOLOGIC ONCOLOGY, 2023, 170 :25-31
[26]   Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study [J].
Zhou, Huimei ;
Liu, Qian ;
Zhang, Depu ;
Li, Qingshui ;
Cao, Dongyan ;
Cheng, Ninghai ;
Wan, Xirun ;
Zhang, Ying ;
Feng, Fengzhi ;
Xiang, Yang ;
Yang, Jiaxin .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (11) :1761-1767
[27]   Gemcitabine in ovarian cancer: An overview of safety and efficacy [J].
Kaufmann, M ;
vonMinckwitz, G .
EUROPEAN JOURNAL OF CANCER, 1997, 33 :S31-S33
[28]   Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer [J].
Takehara, Kazuhiro ;
Matsumoto, Takashi ;
Hamanishi, Junzo ;
Hasegawa, Kosei ;
Matsuura, Motoki ;
Miura, Kiyonori ;
Nagao, Shoji ;
Nakai, Hidekatsu ;
Tanaka, Naotake ;
Tokunaga, Hideki ;
Ushijima, Kimio ;
Watari, Hidemichi ;
Yokoyama, Yoshihito ;
Kase, Yoichi ;
Sumino, Shuuji ;
Suri, Ajit ;
Itamochi, Hiroaki ;
Takeshima, Nobuhiro .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (02) :1-11
[29]   Histopathological Spectrum of Ovarian Neoplasms: A Single-Center Study [J].
Batool, Ayma ;
Rathore, Zonaira ;
Jahangir, Fizza ;
Javeed, Saira ;
Nasir, Saira ;
Chughtai, Akhtar S. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
[30]   Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study [J].
Li, Gaojie ;
Gu, Yuanxia ;
Zou, Qin ;
Wang, Yiyi ;
Xiao, Yue ;
Xia, Dengmei ;
Zhan, Tongying ;
Zhou, Xingli ;
Wang, Qian ;
Yan, Wei ;
Li, Wei .
DERMATOLOGY AND THERAPY, 2022, 12 (09) :2105-2115